{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:07:45Z","timestamp":1789614465006,"version":"build-2803163510"},"reference-count":22,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2019,3,14]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Guidelines state that verapamil is contraindicated in infants. This is based on reports of cardiovascular collapse and even death after rapid intravenous administration of verapamil in infants with supraventricular tachycardia (SVT). We wish to challenge this contraindication for the specific indication of verapamil sensitive ventricular tachycardia (VSVT) in infants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective case series and critical literature review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Hospitals within New Zealand.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>We present a series of three infants\/young children with VSVT or \u2018fascicular VT\u2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Three children aged between 8 days and 2 years presented with tachycardia 200\u2013220 beats per minute with right bundle brunch block and superior axis. Adenosine failed to cardiovert and specialist review diagnosed VSVT. There were no features of cardiovascular shock. Verapamil was given as a slow infusion over 10\u201330\u2009min (rather than as a push) and each successfully cardioverted without incident. Critical review of the literature reveals that cardiovascular collapses were associated with a rapid intravenous push in cardiovascularly compromised infants and\/or infants given other long-acting antiarrhythmics prior to verapamil.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Verapamil is specifically indicated for the treatment of fascicular VT, and for this indication should be used in infancy, as well as in older children, as first-line treatment or after failure of adenosine raises suspicion of the diagnosis. We outline how to distinguish this tachycardia from SVT and propose a strategy for the safe intravenous slow infusion of verapamil in children, noting that extreme caution is necessary with pre-existing ventricular dysfunction.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2018-315617","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T21:24:18Z","timestamp":1555795458000},"page":"789-792","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Fascicular tachycardia in infancy and the use of verapamil: a case series and literature review"],"prefix":"10.1136","volume":"104","author":[{"given":"Jascha","family":"Kehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Binfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3653-0412","authenticated-orcid":false,"given":"Jonathan R","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,4,20]]},"reference":[{"key":"2024091723501020000_104.8.789.1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199107000-00018"},{"key":"2024091723501020000_104.8.789.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(95)00158-1"},{"key":"2024091723501020000_104.8.789.3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000481036","article-title":"The comparative electrophysiologic and hemodynamic effects of verapamil in puppies and adult dogs","volume":"2","author":"Gibson","year":"1981","journal-title":"Dev Pharmacol Ther"},{"key":"2024091723501020000_104.8.789.4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1542\/peds.75.4.737","article-title":"Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia","volume":"75","author":"Epstein","year":"1985","journal-title":"Pediatrics"},{"key":"2024091723501020000_104.8.789.5","doi-asserted-by":"publisher","DOI":"10.1136\/adc.58.6.465"},{"key":"2024091723501020000_104.8.789.6","doi-asserted-by":"publisher","DOI":"10.1136\/adc.62.12.1265"},{"key":"2024091723501020000_104.8.789.7","doi-asserted-by":"publisher","DOI":"10.1097\/00006565-198512000-00007"},{"key":"2024091723501020000_104.8.789.8","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut082"},{"key":"2024091723501020000_104.8.789.9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/PEC.0000000000000307","article-title":"Verapamil-sensitive idiopathic left ventricular tachycardia in a 6-month-old: unique considerations in diagnosis and management in an infant","volume":"31","author":"Hiremath","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"2024091723501020000_104.8.789.10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1747-0803.2006.00020.x","article-title":"Verapamil-sensitive ventricular tachycardia in an infant","volume":"1","author":"Snyder","year":"2006","journal-title":"Congenit Heart Dis"},{"key":"2024091723501020000_104.8.789.11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpeds.2014.08.038","article-title":"Belhassen tachycardia in a 19-month-old child","volume":"166","author":"Huang","year":"2015","journal-title":"J Pediatr"},{"key":"2024091723501020000_104.8.789.12","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1536\/jhj.44.667","article-title":"Verapamil sensitive idiopathic ventricular tachycardia in an infant","volume":"44","author":"Wang","year":"2003","journal-title":"Jpn Heart J"},{"key":"2024091723501020000_104.8.789.13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.46.6.679"},{"key":"2024091723501020000_104.8.789.14","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/oxfordjournals.eurheartj.a061589","article-title":"Fascicular tachycardia sensitive to calcium antagonists","volume":"5","author":"Ward","year":"1984","journal-title":"Eur Heart J"},{"key":"2024091723501020000_104.8.789.15","doi-asserted-by":"publisher","DOI":"10.1111\/jce.12105"},{"key":"2024091723501020000_104.8.789.16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1542\/peds.71.5.748","article-title":"Verapamil: an effective calcium blocking agent for pediatric patients","volume":"71","author":"Porter","year":"1983","journal-title":"Pediatrics"},{"key":"2024091723501020000_104.8.789.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-013-0739-8"},{"key":"2024091723501020000_104.8.789.18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/clc.4960071112","article-title":"The use of calcium gluconate prior to verapamil in infants with paroxysmal supraventricular tachycardia","volume":"7","author":"Roguin","year":"1984","journal-title":"Clin Cardiol"},{"key":"2024091723501020000_104.8.789.19","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1540-8159.1996.tb03195.x","article-title":"Verapamil sensitive incessant ventricular tachycardia in the newborn","volume":"19","author":"Dhala","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024091723501020000_104.8.789.20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1017\/S1047951100006818","article-title":"Verapamil therapy in infants with hypertrophic cardiomyopathy","volume":"8","author":"Moran","year":"1998","journal-title":"Cardiol Young"},{"key":"2024091723501020000_104.8.789.21","unstructured":"Drugs.com. https:\/\/www.drugs.com\/dosage\/verapamil.html#Usual_Pediatric_Dose_for_Supraventricular_Tachycardia."},{"key":"2024091723501020000_104.8.789.22","unstructured":"Shann F . Drug doses. 17 edn. Victoria, Australia: JR Medical Books, 2017:128."}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-315617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T06:52:27Z","timestamp":1726642347000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-315617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,20]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,19]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/archdischild-2018-315617"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-315617","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,20]]}}}